NASDAQ:CYTH   Cyclo Therapeutics, Inc.
Alziehmer play with good vol and Feb 9 Catalyst
milestones for Q1/Q2
1. First Patient In (FPI) for Phase III
(Study 301)
2. Top Line results for completed Phase
I/II (Study 201)
3. Commercial Scale Manufacturing
Batch Pre-IND Meeting Request for AD

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.